quick search
Today:
Home Manufacturing

More Articles

Dr. Ma Jun elaborates on Multi-jurisdiction Common Ground Taxonomy during COP

Nov 20, 2024

BAKU,Azerbaijan,Nov. 19,2024-- On November 14-15,2024,Dr. MaJun,Co-Chair of the IPSF Taxonomy Working Group and Chairman of Capacity-building Alliance of Sustainable Investment (CASI),presented at sev

Introducing the REDTIGER VAC21: The Must-Have Car Vacuum for Utmost Cleanliness

Nov 20, 2024

DALLAS,Nov. 19,2024-- REDTIGER,a leading innovator in automotive accessories,has launched its latest product,the VAC21 car vacuum. This cutting-edge device is set to redefine the standards of portable

MiTAC Computing Unveils New AI/HPC-Optimized Servers with Advanced CPU and GPU Integration at SC24

Nov 20, 2024

ATLANTA,Nov. 20,2024-- MiTAC Computing Technology Corporation,an industry-leading server platform design manufacturer and a subsidiary of MiTAC Holdings Corporation (TSE:3706),is unveiling its new ser

Tuya Announces Anchor Investment by 65 Equity Partners

Nov 19, 2024

SANTA CLARA,Calif.,Nov. 18,2024-- TuyaInc. ("Tuya")(NYSE: TUYA; HKEX: 2391),a global leading cloud platform service provider,today announced that a definitive agreement has been entered into

Mega Matrix Announces that the Romantic Comedy Drama "Tears After 'I Do'" to Be Launched on November 26

Nov 19, 2024

SINGAPORE,Nov. 18,2024-- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU),today announced that it is set to debut the urban romantic comedy Tears After \'I Do\' on N

MSI Powers AI & HPC at SC24 with NVIDIA MGX™ AI Servers and Intel® Xeon® 6 DC-MHS Server Solutions

Nov 19, 2024

ATLANTA,Ga.,Nov. 18,2024-- MSI,a leading global provider of high-performance server solutions,unveiled its AI server based on the NVIDIA MGX™ architecture and DC-MHS server lineup powered by Intel&re

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver

Nov 19, 2024

78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa

17sing teams up with Beldora to create a dream stage: "I wanna be famous"

Nov 19, 2024

TAIPEI,Nov. 19,2024-- There is music,beauty and dreams in this winter! Recently,Taiwan\'s most popular online music social app - 17sing,and the designated skin care brand of Paris and New York Fashion

CASETiFY Expands Into Travel

Nov 18, 2024

NEW YORK,Nov. 15,2024-- CASETiFY is bringing a bold new perspective to the premium travel category with the launch of its most durable,fully customizable,made-to-order luggage collection - CASETiFY T

accesso® Highlights Industry-Leading Guest Experience Solutions at IAAPA Expo Orlando 2024

Nov 18, 2024

ORLANDO,Fla.,Nov. 15,2024-- accesso Technology Group(AIM: ACSO),the premier technology solutions provider for attractions,leisure,entertainment and cultural markets worldwide,with venues in more than

1 ... 3 4 5 6 7 8 9 ... 117

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs